Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Effect of the disclosure of MS diagnosis on anxiety, mood and quality of life of patients: a prospective study.
Cryptococcal meningitis in a multiple sclerosis patient taking natalizumab.
Early MRI activity predicts treatment nonresponse with intramuscular interferon beta-1a in clinically isolated syndrome.
Remote effects of intermittent theta burst stimulation of the human pharyngeal motor system.
Human papillomavirus vaccination, induced autoimmunity, and neuromyelitis optica.
Survey results show that adults are willing to pay higher insurance premiums for generous coverage of specialty drugs.
New technologies for biomarker discovery in multiple sclerosis.
Including known covariates can reduce power to detect genetic effects in case-control studies.
Prognostic indicators for long-term disability in multiple sclerosis patients.
High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis.
Fine-tuning the central nervous system: microglial modelling of cells and synapses.
A Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis (DreaMS)
Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort study.
Chronic cerebrospinal venous insufficiency: Case-control neurosonography results.
Percutaneous transluminal angioplasty for chronic cerebrospinal venous insufficiency in multiple sclerosis: dichotomy between subjective and objective outcome scores.
Update on biomarkers in neuromyelitis optica.
CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation.
Molecular Mechanisms Underlying the Effects of Statins in the Central Nervous System.
Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process.
Cyclophosphamide is effective in stabilizing rapidly deteriorating secondary progressive multiple sclerosis.
Estimated incidence of multiple sclerosis among United States Armed Forces personnel using the Defense Medical Surveillance System.
A2A Adenosine Receptor Signaling in Lymphocytes and the Central Nervous System Regulates Inflammation during Experimental Autoimmune Encephalomyelitis.
Neuromyelitis optica presenting with relapses under treatment with natalizumab: a case report.
Non-steroidal anti-inflammatory drug indometacin enhances endogenous remyelination.
Mesenchymal stem cells as treatment for MS - progress to date.

Pages